Angola - Hospital beds

Hospital beds (per 1,000 people) in Angola was reported at 0.8 in 2005, according to the World Bank collection of development indicators, compiled from officially recognized sources.



angola hospital beds per 1 000 people wb data
width
height
 Preview
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

Learn More Register Login
The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Learn More Interested? Click here to contact us




Hospital beds include inpatient beds available in public, private, general, and specialized hospitals and rehabilitation centers. In most cases beds for both acute and chronic care are included.


Angola | Health

Ratio of school attendance of orphans to school attendance of non-orphans ages 10-14
0.85

15.2 %

10.5 %

14.5 %

16.3 %

25.2 %

11.5 %

43.8 %

39.2 %

30.1 %

27.9 %

23.6 %

70.8 %

57.8 %

50.6 %

48.7 %

37.7 %

79.7 %

69.5 %

63.1 %

61.4 %

47.8 %

41.4 %

43.8 %

34.3 %

23.2 %

16.5 %

85.8 %

75 %

69.6 %

68.7 %

57.5 %
Total alcohol consumption per capita (liters of pure alcohol, projected estimates, 15+ years of age)
7.6
Prevalence of anemia among women of reproductive age (% of women ages 15-49)
47.7 %
Prevalence of anemia among children (% of children under 5)
50.9 %
Prevalence of anemia among non-pregnant women (% of women ages 15-49)
47.2 %

28.7 %

52.8 %

13352
Cause of death, by communicable diseases and maternal, prenatal and nutrition conditions (% of total)
61.8 %
Number of infant deaths
64595
Cause of death, by injury (% of total)
10.7 %
Number of under-five deaths
95905
Cause of death, by non-communicable diseases (% of total)
27.4 %
Number of neonatal deaths
35332

15.4
Adults (ages 15+) living with HIV
260000 Persons
AIDS estimated deaths (UNAIDS estimates)
11000
Female adults with HIV (% of population ages 15+ with HIV)
59.71 %
Prevalence of HIV, total (% of population ages 15-49)
1.9 %
Mortality rate, under-5 (per 1,000)
82.5
Mortality rate, under-5, female (per 1,000 live births)
76.4
Mortality rate, under-5, male (per 1,000 live births)
88.2
Under-5 mortality rate (per 1,000 live births): Q1 (lowest)
102
Under-5 mortality rate (per 1,000 live births): Q2
103
Under-5 mortality rate (per 1,000 live births): Q3
73
Under-5 mortality rate (per 1,000 live births): Q4
66
Under-5 mortality rate (per 1,000 live births): Q5 (highest)
39
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70
25 %
Mortality rate; neonatal (per 1;000 live births)
29.3

19.7

19.2

19.1

19.2

20.5

20.3

19.6

19.7

20.5

22.5

16

16

16.6

16.7

17.5

3.7 %

10.5 %

24.6 %

34.5 %

44.4 %

31.2 %

27.2 %

31.2 %

32.7 %

33.5 %
Median birth interval (months): Q1 (lowest)
28.4
Median birth interval (months): Q2
28.9
Median birth interval (months): Q3
30.5
Median birth interval (months): Q4
34.5
Median birth interval (months): Q5 (highest)
39.9

0.6 %

1.4 %

7.8 %

12.6 %

23.4 %

24.3 %

15.2 %

13.09 %
Children (0-14) living with HIV
23000 Persons
Prevalence of HIV, female (% ages 15-24)
0.8 %
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, female (2 prevent ways and reject 3 misconceptions)
32.5
Comprehensive correct knowledge of HIV/AIDS, ages 15-24, male (2 prevent ways and reject 3 misconceptions)
31.6
Prevalence of HIV, male (% ages 15-24)
0.4 %
Antiretroviral therapy coverage (% of people with advanced HIV infection)
22 %
AIDS deaths in adults and children (high estimate)
16000
AIDS deaths in adults and children (low estimate)
7700
AIDS deaths in adults and children
11000
Adults (ages 15+) newly infected with HIV
21000
Children (ages 0-14) newly infected with HIV
3600
Adults (ages 15+) and children (ages 0-14) newly infected with HIV
25000
Incidence of HIV (% of uninfected population ages 15-49)
0.17 %

31.7 %

35.3 %
Children orphaned by HIV/AIDS
130000
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
44 %
Adults (ages 15+) and children (0-14 years) living with HIV
280000 Persons
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q1 (lowest)
20.4 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q2
18.3 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q3
28.4 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q4
28.1 %
Vaccinations (all vaccinations) (% of children ages 12-23 months): Q5 (highest)
34.7 %
Immunization, Hib3 (% of children ages 12-23 months)
64 %
Immunization, BCG (% of one-year-old children)
58 %
Vaccinations (BCG) (% of children ages 12-23 months): Q1 (lowest)
53.9 %
Vaccinations (BCG) (% of children ages 12-23 months): Q2
56.7 %
Vaccinations (BCG) (% of children ages 12-23 months): Q3
73.4 %
Vaccinations (BCG) (% of children ages 12-23 months): Q4
70.1 %
Vaccinations (BCG) (% of children ages 12-23 months): Q5 (highest)
83.6 %
Immunization, DPT (% of children ages 12-23 months)
64 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q1 (lowest)
23.1 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q2
23.4 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q3
34.4 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q4
36.4 %
Vaccinations (DPT 3) (% of children ages 12-23 months): Q5 (highest)
47.3 %
Immunization, measles (% of children ages 12-23 months)
49 %
Vaccinations (Measles) (% of children ages 12-23 months): Q1 (lowest)
37.8 %
Vaccinations (Measles) (% of children ages 12-23 months): Q2
43.7 %
Vaccinations (Measles) (% of children ages 12-23 months): Q3
56.2 %
Vaccinations (Measles) (% of children ages 12-23 months): Q4
55.2 %
Vaccinations (Measles) (% of children ages 12-23 months): Q5 (highest)
68.2 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q1 (lowest)
14.9 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q2
17.9 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q3
13.7 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q4
10.5 %
Vaccinations (no vaccinations) (% of children ages 12-23 months): Q5 (highest)
8.3 %
Immunization, Pol3 (% of one-year-old children)
66 %
Hospital beds
0.8
Nurses and midwives
1.44
Physicians
0.144
Deaths among children under five years of age due to malaria
8.3 %
Reported malaria deaths (total)
6909
Notified cases of malaria (per 100;000 people)
194337
Mosquito net use by children (any mosquito net) (% of children under 5): Q1 (lowest)
18.4 %
Mosquito net use by children (any mosquito net) (% of children under 5): Q2
27 %
Mosquito net use by children (any mosquito net) (% of children under 5): Q3
29.1 %
Mosquito net use by children (any mosquito net) (% of children under 5): Q4
28.4 %
Mosquito net use by children (any mosquito net) (% of children under 5): Q5 (highest)
26.6 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q1 (lowest)
31.3 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q2
39.5 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q3
42.2 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q4
38.7 %
Household posession of mosquito nets (any type of mosquito net) (% of households): Q5 (highest)
32.7 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q1 (lowest)
20.5 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q2
39.5 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q3
35 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q4
20.8 %
Mosquito net use by pregnant women (any mosquito net) (% of pregnant women): Q5 (highest)
20.9 %
Mosquito net use by children (insecticide-treated net) (% of children under 5): Q2
23.1 %
Mosquito net use by children (insecticide-treated net) (% of children under 5): Q3
23.9 %
Mosquito net use by children (insecticide-treated net) (% of children under 5): Q4
23 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q1 (lowest)
27.5 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q2
33.8 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q3
34.8 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q4
30.7 %
Household posession of mosquito nets (insecticide-treated net) (% of households): Q5 (highest)
26.9 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q1 (lowest)
18.3 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q2
33.7 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q3
27.4 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q4
15.3 %
Mosquito net use by pregnant women (insecticide-treated net) (% of pregnant women): Q5 (highest)
15.9 %
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q1 (lowest)
29.1 %
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q2
54.7 %
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q3
75 %
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q4
78.9 %
Anti-malarial drug use by pregnant women (any antimalarial drug) (% of women with a birth): Q5 (highest)
79.2 %
Use of Intermittent Preventive Treatment of malaria, 2+ doses of SP/Fansidar (% of pregnant women)
17.5 %
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q1 (lowest)
19.1 %
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q2
31.2 %
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q3
44.1 %
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q4
48.2 %
Anti-malarial drug use by pregnant women (SP/Fansidar two or more doses) (% of women with a birth): Q5 (highest)
58.5 %
Treatment of fever (% of children under 5 with fever): Q1 (lowest)
15.3 %
Treatment of fever (% of children under 5 with fever): Q2
17.8 %
Treatment of fever (% of children under 5 with fever): Q3
17.5 %
Treatment of fever (% of children under 5 with fever): Q4
19.3 %
Treatment of fever (% of children under 5 with fever): Q5 (highest)
23.4 %
Children with fever receiving antimalarial drugs (% of children under age 5 with fever)
28.3 %
Number of maternal mortality deaths
5400
Lifetime risk of maternal death (1 in: rate varies by country)
32
Lifetime risk of maternal death
3.08 %
Prevalence of anemia among pregnant women
50.8 %

3.8 %

2.7 %

1.3 %

1.2 %

1.3 %
Risk of catastrophic expenditure for surgical care (% of people at risk)
51.4 %
Risk of impoverishing expenditure for surgical care (% of people at risk)
55.5 %

48.4 %

63.6 %

80.5 %

90.6 %

94.9 %
Pregnant women receiving prenatal care of at least four visits (% of pregnant women)
61.4 %
Antenatal care (any skilled personnel) (% of women with a birth): Q1 (lowest)
56.6 %
Antenatal care (any skilled personnel) (% of women with a birth): Q2
72.1 %
Antenatal care (any skilled personnel) (% of women with a birth): Q3
89.4 %
Antenatal care (any skilled personnel) (% of women with a birth): Q4
96.1 %
Antenatal care (any skilled personnel) (% of women with a birth): Q5 (highest)
97.9 %
Pregnant women receiving prenatal care
81.6 %
Antenatal care (doctor) (% of women with a birth): Q1 (lowest)
3.4 %
Antenatal care (doctor) (% of women with a birth): Q2
7.7 %
Antenatal care (doctor) (% of women with a birth): Q3
15 %
Antenatal care (doctor) (% of women with a birth): Q4
22.3 %
Antenatal care (doctor) (% of women with a birth): Q5 (highest)
30.6 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q1 (lowest)
25.2 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q2
45.4 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q3
46.8 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q4
66.4 %
Treatment of acute respiratory infection (ARI) (% of children under 5 taken to a health provider): Q5 (highest)
77.9 %
ARI treatment (% of children under 5 taken to a health provider)
49 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q1 (lowest)
3.6 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q2
3 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q3
3.5 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q4
3.1 %
Prevalence of acute respiratory infection (ARI) (% of children under 5): Q5 (highest)
3.2 %
Exclusive breastfeeding (% of children under 6 months)
37.38 %
Assistance during delivery (any skilled personnel) (% of births): Q1 (lowest)
18.9 %
Assistance during delivery (any skilled personnel) (% of births): Q2
29.5 %
Assistance during delivery (any skilled personnel) (% of births): Q3
58.6 %
Assistance during delivery (any skilled personnel) (% of births): Q4
76.8 %
Assistance during delivery (any skilled personnel) (% of births): Q5 (highest)
89.3 %
Births attended by skilled health staff (% of total)
49.6 %
Place of delivery (births at health facility) (% of births): Q1 (lowest)
13.2 %
Place of delivery (births at health facility) (% of births): Q2
24.9 %
Place of delivery (births at health facility) (% of births): Q3
55.7 %
Place of delivery (births at health facility) (% of births): Q4
74 %
Place of delivery (births at health facility) (% of births): Q5 (highest)
86.1 %
Assistance during delivery (doctor) (% of births): Q1 (lowest)
1.2 %
Assistance during delivery (doctor) (% of births): Q2
3.3 %
Assistance during delivery (doctor) (% of births): Q3
6.3 %
Assistance during delivery (doctor) (% of births): Q4
11.2 %
Assistance during delivery (doctor) (% of births): Q5 (highest)
23.5 %
Low-birthweight babies (% of births)
12 %
Prevalence of diarrhea (% of children under 5): Q1 (lowest)
18.6 %
Prevalence of diarrhea (% of children under 5): Q2
20.4 %
Prevalence of diarrhea (% of children under 5): Q3
20.1 %
Prevalence of diarrhea (% of children under 5): Q4
21.9 %
Prevalence of diarrhea (% of children under 5): Q5 (highest)
22.2 %
Prevalence of children with fever (% of children under 5): Q1 (lowest)
16.3 %
Prevalence of children with fever (% of children under 5): Q2
16.3 %
Prevalence of children with fever (% of children under 5): Q3
13.4 %
Prevalence of children with fever (% of children under 5): Q4
13.7 %
Prevalence of children with fever (% of children under 5): Q5 (highest)
12.5 %

13.26 %
Prevalence of underweight, weight for age, female (% of children under 5)
14.6 %
Prevalence of underweight, weight for age, male (% of children under 5)
16.6 %

26.9 %

22.4 %

17.1 %

12.1 %

7.8 %
Malnutrition prevalence, weight for age (% of children under 5)
15.6 %
Malaria cases reported
2769305

8.5 %

6.1 %

4.7 %

2.2 %

1.4 %
Maternal mortality ratio (modeled estimate, per 100,000 live births)
477
Diarrhea treatment (% of children under 5 receiving oral rehydration and continued feeding)
39.7 %

64.1 %

53.5 %

40.4 %

43.3 %

28.3 %

60.2 %

56.5 %

69.6 %

79.1 %

89.7 %

31.1 %

37.9 %

53.2 %

44.4 %

57.3 %
Diarrhea treatment (% of children under 5 who received ORS packet)
42.6 %
Prevalence of overweight, female (% of female adults)
34.9 %
Prevalence of overweight, male (% of male adults)
19.5 %

27.5 %
Prevalence of overweight, weight for height, female (% of children under 5)
5.5 %
Prevalence of overweight, weight for height, male (% of children under 5)
5.1 %
Prevalence of overweight (% of children under 5)
5.3 %

23.6 %

17.9 %

13.7 %

8.7 %

7 %
Prevalence of stunting, height for age, female (% of children under 5)
26.1 %
Prevalence of stunting, height for age, male (% of children under 5)
32.4 %

47.3 %

45.1 %

38.8 %

26.6 %

20.4 %
Malnutrition prevalence, height for age (% of children under 5)
29.2 %
Mortality caused by road traffic injury (per 100,000 people)
24.4
Prevalence of wasting, weight for height, female (% of children under 5)
8.1 %
Prevalence of wasting, weight for height, male (% of children under 5)
8.2 %

5.6 %

5.3 %

4.9 %

4.1 %

3.6 %
Prevalence of wasting (% of children under 5)
8.2 %

1.3 %

1.5 %

1 %

0.6 %

0.1 %
Prevalence of severe wasting, weight for height, female (% of children under 5)
4.2 %
Prevalence of severe wasting, weight for height, male (% of children under 5)
4.3 %
Prevalence of severe wasting, weight for height (% of children under 5)
4.3 %
Tuberculosis treatment success rate (% of registered cases)
34 %
Tuberculosis case detection rate (all forms)
56 %
Incidence of tuberculosis (per 100,000 people)
370
Tuberculosis death rate (per 100,000 people)
64
Deaths due to tuberculosis among HIV-negative people, high uncertainty bound (per 100,000 population)
66
Deaths due to tuberculosis among HIV-negative people, low uncertainty bound (per 100,000 population)
17

278000 %

1.28 %

0.0436

437000

0.0147 %

2.01 %

0.0141

555000

0.00773 %

2.55 %

2694000 %

12.38 %

988000 %

4.54 %

1699000 %

7.81 %

36

35.3 %

43.3 %

59.8 %

68.5 %

77 %
Newborns protected against tetanus
78 %
External resources for health (% of total expenditure on health)
42.09 %
Out-of-pocket health expenditure (% of total expenditure on health)
383 %
Out-of-pocket health expenditure (% of private expenditure on health)
1073 %
Health expenditure per capita
2870 USD
Health expenditure per capita, PPP (constant 2005 international $)
3824
Health expenditure, private (% of GDP)
18.91 %
Health expenditure, public (% of total health expenditure)
1028 %
Health expenditure, public (% of government expenditure)
80.07 %
Health expenditure, public (% of GDP)
34 %
Health expenditure, total (% of GDP)
52.91 %
Number of people who are undernourished
3500000
Depth of the food deficit (kilocalories per person per day)
90
Depth of hunger (kilocalories per person per day)
320
Consumption of iodized salt (% of households)
44.7 %
Vitamin A supplements for postpartum women (% of women with a birth): Q1 (lowest)
18.7 %
Vitamin A supplements for postpartum women (% of women with a birth): Q2
23.4 %
Vitamin A supplements for postpartum women (% of women with a birth): Q3
30.9 %
Vitamin A supplements for postpartum women (% of women with a birth): Q4
27.5 %
Vitamin A supplements for postpartum women (% of women with a birth): Q5 (highest)
26.1 %
Vitamin A supplements for children (% of children ages 6-59 months): Q1 (lowest)
3 %
Vitamin A supplements for children (% of children ages 6-59 months): Q2
3.3 %
Vitamin A supplements for children (% of children ages 6-59 months): Q3
4.9 %
Vitamin A supplements for children (% of children ages 6-59 months): Q4
7.2 %
Vitamin A supplements for children (% of children ages 6-59 months): Q5 (highest)
12.9 %
Vitamin A supplementation coverage rate (% of children ages 6-59 months)
14 %
Adolescent fertility rate (births per 1,000 women ages 15-19)
154
Mortality rate, adult, female (per 1,000 female adults)
203
Mortality rate, adult, male (per 1,000 male adults)
277
Birth rate, crude
41.82
Death rate, crude
8.51
Mean number of children ever born to women aged 40-49: Q1 (lowest)
7
Mean number of children ever born to women aged 40-49: Q2
7.3
Mean number of children ever born to women aged 40-49: Q3
6.9
Mean number of children ever born to women aged 40-49: Q4
6.4
Mean number of children ever born to women aged 40-49: Q5 (highest)
5.5
Current use of contraception (modern method) (% of married women): Q1 (lowest)
1 %
Current use of contraception (modern method) (% of married women): Q2
2.6 %
Current use of contraception (modern method) (% of married women): Q3
8.9 %
Current use of contraception (modern method) (% of married women): Q4
18.5 %
Current use of contraception (modern method) (% of married women): Q5 (highest)
30.7 %
Contraceptive prevalence, modern methods (% of women ages 15-49)
12.5 %
Current use of contraception (any method) (% of married women): Q1 (lowest)
1.3 %
Current use of contraception (any method) (% of married women): Q2
3.3 %
Current use of contraception (any method) (% of married women): Q3
9.8 %
Current use of contraception (any method) (% of married women): Q4
20.2 %
Current use of contraception (any method) (% of married women): Q5 (highest)
32.6 %
Contraceptive prevalence (% of women ages 15-49)
13.7 %
Mortality rate, infant, female (per 1,000 live births)
49
Mortality rate, infant (per 1,000 live births)
54.6
Mortality rate, infant, male (per 1,000 live births)
60
Infant mortality rate (per 1,000 live births): Q1 (lowest)
62
Infant mortality rate (per 1,000 live births): Q2
64
Infant mortality rate (per 1,000 live births): Q3
47
Infant mortality rate (per 1,000 live births): Q4
43
Infant mortality rate (per 1,000 live births): Q5 (highest)
25
Life expectancy at birth, female (years)
64.41 years
Life expectancy at birth, total (years)
61.55 years
Life expectancy at birth, male (years)
58.72 years
Fertility rate, total (births per woman)
5.69
Total fertility rate (TFR) (births per woman): Q1 (lowest)
8.5
Total fertility rate (TFR) (births per woman): Q2
8.2
Total fertility rate (TFR) (births per woman): Q3
6.8
Total fertility rate (TFR) (births per woman): Q4
4.7
Total fertility rate (TFR) (births per woman): Q5 (highest)
4
Survival to age 65, female (% of cohort)
65.91 %
Survival to age 65, male (% of cohort)
55.9 %

5.2

7.4

7.2

5.4

3.9

3.3
Female headed households (% of households with a female head)
34.5 %

30.3 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q1 (lowest)
47.8 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q2
58.2 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q3
41.4 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q4
25.3 %
Teenage pregnancy and motherhood (% of women ages 15-19 who have had children or are currently pregnant): Q5 (highest)
15.9 %
Teenage mothers (% of women ages 15-19 who have had children or are currently pregnant)
34.5 %
Completeness of birth registration, rural
13.6 %
Completeness of birth registration, urban
32.9 %
Completeness of birth registration
25 %

12.5 %

11.7 %

13.3 %

12.4 %

9.8 %

22.2 %

28.1 %

32 %

26.5 %

21 %

38 %

34.7 %

39.7 %

45.3 %

38.9 %

30.7 %






Related
Latest